Dr. Meldrum et al., CARDIAC PRECONDITIONING WITH CALCIUM - CLINICALLY ACCESSIBLE MYOCARDIAL PROTECTION, Journal of thoracic and cardiovascular surgery, 112(3), 1996, pp. 778-786
Cardiac preconditioning is mediated by protein kinase C. Although endo
genous calcium is a potent stimulus of protein kinase C, it remains un
known whether preischemic administration of exogenous calcium can indu
ce protein kinase C-mediated myocardial protection against ischemia-re
perfusion injury. To study this, calcium chloride was administered ret
rogradely through the aorta at a rate 5 nmol/min for 2 minutes to isol
ated perfused rat hearts 10 minutes before a 20-minute ischemia and 10
-minute reperfusion insult, Calcium-mediated cardioadaptation was then
linked to protein kinase C by means of the protein kinase C inhibitor
chelerythrine (20 mu mol . L(-1). 2 min(-1)). To determine whether ex
ogenous calcium administration induces protein kinase C translocation
and activation, immunohistochemical staining for the calcium-dependent
protein kinase C isoform a was performed on adjacent 5 mu m myocardia
l sections with and without calcium chloride treatment. Results indica
ted that preischemic calcium chloride administration improved myocardi
al functional recovery, as determined by enhanced developed pressure,
improved coronary how, reduced end-diastolic pressure, and decreased c
reatine kinase leakage during reperfusion, Beneficial effects of calci
um chloride were eliminated by concurrent protein kinase C inhibition,
Immunohistochemical staining for the a isoform of protein kinase C de
monstrated that calcium chloride induces translocation of this isoform
from the cytoplasm to the sarcolemma, indicating that exogenous calci
um administration activates this isoform, These results suggest that c
alcium chloride, a safe and routinely administered agent, can induce p
rotein kinase C-mediated cardiac preconditioning. Calcium-induced card
ioadaptation to ischemia-reperfusion injury may be promising as a clin
ically feasible therapy before planned ischemic events such as cardiac
allograft preservation and elective cardiac operations.